Losartan effectiveness
Pro Research Analysisby 
Searched over 200M research papers for "losartan effectiveness"
Losartan Effectiveness: A Comprehensive Review
Losartan for Diabetic Nephropathy and Renal Outcomes
Losartan, an angiotensin-II-receptor antagonist, has shown significant benefits in patients with type 2 diabetes and nephropathy. In a large randomized, double-blind study involving 1513 patients, losartan was found to reduce the incidence of a doubling of serum creatinine concentration by 25% and end-stage renal disease (ESRD) by 28% compared to placebo 16. Additionally, losartan significantly decreased proteinuria levels by 35%, indicating its effectiveness in slowing the progression of renal disease beyond its blood pressure-lowering effects .
Losartan vs. Atenolol in Marfan Syndrome
In patients with Marfan syndrome, losartan was compared to atenolol for its efficacy in preventing aortic dilation. Over a 3-year period, both drugs showed similar results in terms of aortic root and ascending aorta diameter progression, with no significant differences between the two groups . This suggests that while losartan is effective, it does not offer superior benefits over atenolol in this specific condition.
Losartan in Hypertension Management
Losartan has been extensively studied for its antihypertensive properties. Clinical trials have demonstrated that losartan, either alone or in combination with hydrochlorothiazide (HCTZ), effectively lowers blood pressure in patients with mild to severe hypertension 37. The combination of losartan and HCTZ was particularly beneficial for patients who were inadequately controlled on other antihypertensive therapies, showing significant improvements in blood pressure control and a reduction in therapy-related side effects .
Losartan in Post-Dialysis Hypertension
In a study focusing on post-dialysis euvolemic hypertensive patients, losartan 50 mg administered every other day significantly reduced blood pressure over an 8-week period compared to standard antihypertensive treatments . This highlights losartan's potential as an effective option for managing hypertension in dialysis patients.
Losartan in Ovarian Cancer Treatment
Beyond its cardiovascular and renal benefits, losartan has shown promise in enhancing chemotherapy efficacy in ovarian cancer models. By normalizing the tumor stroma and reducing extracellular matrix content, losartan improved drug delivery and reduced ascites, a common complication in ovarian cancer patients . These findings suggest a potential role for losartan in cancer therapy, warranting further clinical trials.
Losartan's Anti-Atherosclerotic Effects
In animal models, losartan has demonstrated significant antiatherogenic properties. It inhibited LDL lipid peroxidation and reduced atherosclerotic lesion areas by 80% in apolipoprotein E-deficient mice, indicating its potential in preventing atherosclerosis . Additionally, losartan was effective in reducing myocardial ischemia-induced ventricular arrhythmias and reperfusion injury in hypertensive rats, further supporting its cardiovascular protective effects .
Conclusion
Losartan is a versatile medication with proven efficacy in managing hypertension, protecting renal function in diabetic nephropathy, and potentially enhancing cancer treatment. Its benefits extend to reducing cardiovascular risks and improving outcomes in various patient populations. These findings underscore the importance of losartan in clinical practice and its potential for broader therapeutic applications.
Sources and full results
Most relevant research papers on this topic